Despite some reluctance for some, all of the nearly 200 residents of the EHPAD des Bateliers in Lille have been vaccinated. The establishment was even at the end of December the first in the region to be able to inject a dose of the Pfizer vaccine. Today, the Covid no longer circulates in the EHPAD. No more cases of Covid-19 contamination have been identified among residents.
It is for this reason thata team of researchers from the Lille University Hospital, led by Guillaume Lefevre, will conduct a study on the effectiveness of the Pfizer vaccine on the elderly. 125 residents of the EHPAD, who underwent a first blood test before vaccination to assess their metabolism, will have to undergo a second blood test three months after being vaccinated, then a third nine months after this vaccination. Their results will be compared with those of 125 nursing home care workers who also received a dose of the vaccine.
First results known before the summer
“EHPAD residents are a very particular population, very vulnerable, by their age, by their immune system which responds less well to a virus but which will also be less reactive to a vaccine and then they have comorbidities such as diabetes or hyper tension which can lead to severe forms “, details Guillaume Lefevre, the doctor in charge of the study. He also specifies that the elderly cannot participate in therapeutic studies carried out before the vaccines are made available.
The first results of this study will be known in the summer, after the first blood test of the three. Guillaume Lefevre specifies that the data of this study “will be used, one hopes, for a strategy of vaccination of the elderly in France”.
–
